Through M2-polarization of tumor-associated macrophages, EGF secreted by colon cancer cells enhances the cancer-driving effect of the tumor microenvironment [52], then promoting immuno-suppression, angiogenesis and neovascularization, as well as stromal activation and remodeling. Here, EGF is linked to malignant colon neoplasm.